Skip to main content
OpenTrials
Completed

NCT Number: NCT00725166

Human Muscle Gene Expression Profiles in Young and Old Men

To reach the goals of living longer in better medical conditions, many countries reach the same conclusion: new strategies have to be developed to avoid, or at least limit, the effects of age; this requires a better knowledge of the mechanisms of aging. Our project focuses on the loss of muscle mass associated with aging, called sarcopenia. Sarcopenia unavoidably leads to impaired mobility and poor balance, which contributes to loss of functional autonomy and to increased prevalence for severe falls. Skeletal muscle also plays a central role as a reserve for energy and amino acids. Hence, sarcopenia further triggers severe side metabolic effects such as frailty among elderly persons. The precise mechanisms of muscle aging are still mostly unknown, although many theories have been proposed.

The present study aims at better understanding the mechanisms of skeletal muscle loss associated with aging. Using muscle biopsies from young and old subjects, the differential expression profiles of mRNA will be obtained through chips that will evaluate more than 39000 transcripts. On the same samples, proteomic analyses will involve two complementary approaches: (1) bidimensional electrophoresis (2DGE) coupled to mass spectrometry (MALDI-ToF) for dominant proteins; (2) Western-blot (more than 800 antibodies) targeting regulating proteins not detectable using 2DGE. Complementary histological studies (immunohisto-fluorescence, confocal microscopy) will specify the localisation of the major biomarkers in the muscle biopsies.

The results of that research will have applications in the medium term and will lead to nutritional interventions to modulate specific metabolic pathways and improve the quality of life in the elderly.

Completed

Looking for future studies?

Notify Me

Key information

Age range

19 year–76 year

Sex eligibility

Male

Study type

Observational

Primary location

CHU de Saint-Etienne

Saint-Etienne, 42000, France

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Affiliated or beneficiary of a social security category
  • Having signed the inform consent form
  • Having signed the genetic consent form

Exclusion criteria

  • Antiaggregant platelet treatment
  • Type 2 diabetes
  • Body Mass Index > 25
  • Severe renal disease
  • CRP > 10
  • Abnormal clotting test
  • Allergies to local anesthetics

Treatment and study plan

Skeletal muscle aging

Other

W1 - Blood test

  • Maximal voluntary contraction of quadriceps
  • Hydrostatic weighing

W2 - Maximal metabolic test using a cycloergometer

W3 - Muscular biopsy

Primary outcomes

  1. To identify the differential expression profiles (proteomics, transcriptomics) in skeletal muscle between young and old men

    Time frame: During biopsie (W3)

Secondary outcomes

  1. To specify the localisation of the major biomarkers in the muscle biopsies.

    Time frame: During biopsie (W3)

  2. To compare muscular energy metabolic enzymatic activities between young and old men

    Time frame: during biopsie (W3)

  3. To compare the number of muscular stem cells between young and old men

    Time frame: during biopsie (W3)

Sponsors and collaborators

Lead sponsor

Centre Hospitalier Universitaire de Saint Etienne

Other

Collaborators

  • Fondation des Caisses d'Epargne Rhône-Alpes
  • Institut National de Recherche pour l'Agriculture, l'Alimentation et l'Environnement

Registry information

Acronym: CERA

Important dates

Study start
2008
Primary completion
2009
Study completion
2009
First posted
Jul 30, 2008
Registry last updated
Jun 11, 2009

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.